Micardis 40 mg Tablets (Telmisartan)

Adult dose

1. Essential Hypertension Take 40 mg of Telmisartan once daily with water, with or without food. In some patients, 20 mg once daily may be effective, and if necessary, the dose can be increased to 80 mg once daily. Dose increases will show maximum blood pressure-lowering effects 4-8 weeks after starting treatment. 2. Reduction of Cardiovascular Disease Risk Take this medication once daily.

This drug can cause severe harm to the fetus and newborn during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug or its components, pregnant or breastfeeding women, patients with severe liver disease or biliary excretion disorders, patients with hereditary angioedema, and patients with diabetes or severe renal impairment should not take this medication. Caution is advised for elderly patients, patients with hyperkalemia, patients with mild to moderate liver dysfunction, patients with heart valve disease, patients with ischemic heart disease, patients with gastrointestinal disorders, patients with renovascular hypertension, and patients with severe renal impairment. Blood pressure, renal function, and serum potassium levels should be regularly monitored during treatment, especially when this medication is used in combination with other blood pressure medications or potassium supplements. Side effects such as dizziness, headache, cough, dyspepsia, skin rash, angioedema, myalgia, renal function abnormalities, etc. may occur, so if any unusual symptoms arise, consult a healthcare professional immediately. This medication lowers blood pressure, and in the event of hypotension, measures such as laying the patient down and administering fluids may be necessary. It is advisable not to take this medication for 24 hours before surgery, and caution is required when driving or operating machinery due to the risk of dizziness or fainting. This medication contains sorbitol and is not suitable for patients with fructose intolerance. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women should also avoid it. In cases of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur; therefore, if symptoms arise, seek medical attention immediately. The safety and efficacy for children and adolescents under 18 years of age have not been established and are not recommended. This drug may enhance the blood-lowering effect when used in combination with other antihypertensive medications, and may interact with specific drugs; therefore, it is essential to inform healthcare professionals of any other medications being taken.

Serious side effects

Urticaria, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling skin, pain in oral or ocular mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, dramatically decreased urine output

Mild side effects

• Upper respiratory infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help preserve the medication's efficacy and safety.

Appearance

This medicine is a white or off-white, oval-shaped tablet that is biconvex.

Package unit

30 tablets (10 tablets/PTP x 3)